当前位置：
X-MOL 学术
›
J. Antimicrob. Chemother.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir
Journal of Antimicrobial Chemotherapy ( IF 3.9 ) Pub Date : 2021-08-17 , DOI: 10.1093/jac/dkab309 Francesco Saladini 1 , Alessia Giannini 1 , Federica Giammarino 1 , Adele Boccuto 1 , Filippo Dragoni 1 , Ilaria Vicenti 1 , Maurizio Zazzi 1
Journal of Antimicrobial Chemotherapy ( IF 3.9 ) Pub Date : 2021-08-17 , DOI: 10.1093/jac/dkab309 Francesco Saladini 1 , Alessia Giannini 1 , Federica Giammarino 1 , Adele Boccuto 1 , Filippo Dragoni 1 , Ilaria Vicenti 1 , Maurizio Zazzi 1
Affiliation
European Union’s Horizon 2020 programme and the Ministry of Science and Higher Education of the Russian Federation
中文翻译：
HIV-1 CRF02_AG 对 temsavir（附着抑制剂 fostemsavir 的活性化合物）的体外敏感性
欧盟地平线 2020 计划和俄罗斯联邦科学和高等教育部
更新日期：2021-08-17
中文翻译：
HIV-1 CRF02_AG 对 temsavir（附着抑制剂 fostemsavir 的活性化合物）的体外敏感性
欧盟地平线 2020 计划和俄罗斯联邦科学和高等教育部
京公网安备 11010802027423号